Morgan Advanced Materials
MGAM · Main Market · Industrial Goods and Services · mcap £802m · 288.0p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 29 Sep 26 | Director dealing | Director/PDMR Shareholding | |
| 28 Aug 26 | Disposal of shareholding in Foseco India Limited
Completed disposal of 15% shareholding in Foseco India for £53m net proceeds, to reduce net debt. |
+1.5% | |
| 06 Aug 26 | Investor Presentation via Investor Meet Company
Morgan Advanced Materials plc, the global leader in advanced ceramics and carbon systems for technologically demanding applications, is pleased to announce that Damien Caby, Group CEO, and Richard Armitage, Group CFO, wi |
+2.1% | |
| 06 Aug 26 | Results | Half-year Results
H1 2026 revenue £518.1m up 3.1%, adjusted operating profit margin 11.2%, targeting 12% by 2028. |
+2.1% |
| 23 Jul 26 | Holding | Holding(s) in Company | |
| 01 Jun 26 | Director dealing | Director/PDMR Shareholding | |
| 28 May 26 | Holding | Holding(s) in Company | |
| 26 May 26 | Director dealing | Director/PDMR Shareholding | |
| 18 May 26 | Holding | Holding(s) in Company | |
| 13 May 26 | Holding | Holding(s) in Company | |
| 12 May 26 | Director dealing | Director/PDMR Shareholding | |
| 07 May 26 | Routine | Result of AGM | |
| 07 May 26 | Board change | CFO Intention to retire
CFO Richard Armitage to retire in first half of 2027; succession process underway. |
−0.4% |
| 07 May 26 | Trading update | AGM Trading Update
Q1 revenue grew 6.2% organically; full-year 2026 guidance maintained unchanged. |
−0.4% |
| 29 Apr 26 | Director dealing | Director/PDMR Shareholding | |
| 09 Apr 26 | Holding | Holding(s) in Company | |
| 31 Mar 26 | Director dealing | Director/PDMR Shareholding | |
| 26 Mar 26 | Director dealing | Director/PDMR Shareholding | |
| 26 Mar 26 | Results | Annual Report
Publication of 2025 Annual Report and Notice of 2026 Annual General Meeting |
−0.1% |
| 24 Mar 26 | Director dealing | Director/PDMR Shareholding | |
| 09 Mar 26 | Director dealing | Director/PDMR Shareholding | |
| 05 Mar 26 | Director dealing | Director/PDMR Shareholding | |
| 03 Mar 26 | Results | Final Results
Full year 2025 revenue £1,030.3m down 3.3% on organic constant currency basis; operating margin 9.6% reflecting end-market weakness partially offset by efficiency gains. |
−13.7% |
| 23 Feb 26 | Holding | Holding(s) in Company | |
| 02 Feb 26 | Routine | Total Voting Rights | |
| 02 Feb 26 | Holding | Holding(s) in Company | |
| 12 Jan 26 | Routine | Transaction in Own Shares | |
| 09 Jan 26 | Routine | Transaction in Own Shares | |
| 08 Jan 26 | Routine | Transaction in Own Shares | |
| 07 Jan 26 | Routine | Transaction in Own Shares | |
| 06 Jan 26 | Routine | Transaction in Own Shares | |
| 05 Jan 26 | Routine | Transaction in Own Shares | |
| 02 Jan 26 | Routine | Total Voting Rights | |
| 02 Jan 26 | Routine | Transaction in Own Shares | |
| 31 Dec 25 | Routine | Transaction in Own Shares | |
| 30 Dec 25 | Routine | Transaction in Own Shares | |
| 29 Dec 25 | Routine | Transaction in Own Shares | |
| 24 Dec 25 | Routine | Transaction in Own Shares | |
| 23 Dec 25 | Routine | Transaction in Own Shares | |
| 22 Dec 25 | Routine | Block listing Interim Review | |
| 22 Dec 25 | Routine | Transaction in Own Shares | |
| 19 Dec 25 | Routine | Transaction in Own Shares | |
| 18 Dec 25 | Routine | Transaction in Own Shares | |
| 17 Dec 25 | Routine | Transaction in Own Shares | |
| 16 Dec 25 | Routine | Transaction in Own Shares | |
| 15 Dec 25 | Routine | Transaction in Own Shares | |
| 12 Dec 25 | Routine | Transaction in Own Shares | |
| 11 Dec 25 | Routine | Transaction in Own Shares | |
| 10 Dec 25 | Routine | Transaction in Own Shares | |
| 09 Dec 25 | Routine | Transaction in Own Shares | |
| 08 Dec 25 | Routine | Transaction in Own Shares | |
| 05 Dec 25 | Routine | Transaction in Own Shares | |
| 04 Dec 25 | Strategy Update
Company sets out strategy focused on operational transformation, growth and portfolio optimization with updated financial targets. |
+0.7% | |
| 04 Dec 25 | Routine | Transaction in Own Shares | |
| 03 Dec 25 | Routine | Transaction in Own Shares | |
| 02 Dec 25 | Routine | Transaction in Own Shares | |
| 01 Dec 25 | Routine | Total Voting Rights | |
| 01 Dec 25 | Routine | Transaction in Own Shares | |
| 28 Nov 25 | Routine | Transaction in Own Shares | |
| 27 Nov 25 | Routine | Transaction in Own Shares | |
| 26 Nov 25 | Routine | Transaction in Own Shares | |
| 25 Nov 25 | Routine | Transaction in Own Shares | |
| 24 Nov 25 | Routine | Transaction in Own Shares | |
| 21 Nov 25 | Routine | Transaction in Own Shares | |
| 20 Nov 25 | Routine | Transaction in Own Shares | |
| 19 Nov 25 | Routine | Transaction in Own Shares | |
| 18 Nov 25 | Routine | Transaction in Own Shares | |
| 17 Nov 25 | Routine | Transaction in Own Shares | |
| 14 Nov 25 | Routine | Transaction in Own Shares | |
| 13 Nov 25 | Routine | Transaction in Own Shares | |
| 13 Nov 25 | Completion of Sale of MMS business
Morgan Advanced Materials completed the sale of its Molten Metal Systems business on 12 November 2025. |
−1.2% | |
| 12 Nov 25 | Routine | Transaction in Own Shares | |
| 11 Nov 25 | Routine | Transaction in Own Shares | |
| 10 Nov 25 | Holding | Holding(s) in Company | |
| 10 Nov 25 | Routine | Transaction in Own Shares | |
| 07 Nov 25 | Routine | Transaction in Own Shares | |
| 06 Nov 25 | Routine | Transaction in Own Shares | |
| 05 Nov 25 | Routine | Transaction in Own Shares | |
| 04 Nov 25 | Routine | Transaction in Own Shares | |
| 03 Nov 25 | Routine | Total Voting Rights | |
| 03 Nov 25 | Routine | Transaction in Own Shares | |
| 31 Oct 25 | Routine | Transaction in Own Shares | |
| 30 Oct 25 | Routine | Transaction in Own Shares | |
| 29 Oct 25 | Routine | Transaction in Own Shares | |
| 28 Oct 25 | Routine | Transaction in Own Shares | |
| 27 Oct 25 | Routine | Transaction in Own Shares | |
| 24 Oct 25 | Routine | Transaction in Own Shares | |
| 23 Oct 25 | Routine | Transaction in Own Shares | |
| 22 Oct 25 | Routine | Transaction in Own Shares | |
| 21 Oct 25 | Routine | Transaction in Own Shares | |
| 20 Oct 25 | Routine | Transaction in Own Shares | |
| 17 Oct 25 | Routine | Transaction in Own Shares | |
| 16 Oct 25 | Routine | Transaction in Own Shares | |
| 15 Oct 25 | Routine | Transaction in Own Shares | |
| 14 Oct 25 | Trading update | Trading Update
Q3 sales 1.6% higher year-on-year but full-year expected 4% lower on weak semiconductor demand and European uncertainty. |
−6.6% |
| 14 Oct 25 | Routine | Transaction in Own Shares | |
| 13 Oct 25 | Routine | Transaction in Own Shares | |
| 10 Oct 25 | Routine | Transaction in Own Shares | |
| 09 Oct 25 | Routine | Transaction in Own Shares | |
| 08 Oct 25 | Routine | Transaction in Own Shares | |
| 07 Oct 25 | Routine | Transaction in Own Shares | |
| 06 Oct 25 | Board change | Directorate Change
Professor Mary Ryan CBE appointed as non-executive director, effective 1 November 2025. |
−1.7% |
| 06 Oct 25 | Routine | Transaction in Own Shares |
Company filings. Not investment advice.